NCT02389400View on ClinicalTrials.gov

Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Langerhans Cell Histiocytosis
Interventions
DRUG

methotrexate

Single Group Assignment

Trial Locations (1)

100730

Peking union medical college hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT02389400 - Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis | Biotech Hunter | Biotech Hunter